2m 2m 2m 2m 2m 2m 2m
Sibannac (SNNC)
OTC
$0.005-$0.0003 (-5.60%)
Price as of Sep 11, 2026- N/AMarket Cap
- -74.47%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Sibannac (SNNC)
$0.005-$0.0003 (-5.60%)
SNNC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.00 | ||
Change | -$0.0003 (-5.60%) | ||
Open | $0.00 | ||
High | $0.00 | ||
Low | $0.00 | ||
Previous Close | $0.01 | ||
Volume | 20,000 | ||
30-Day Average Volume | 450,378 | ||
1-Week Change | -1.15% | ||
1-Month Change | -42.44% | ||
1-Year Change | -74.47% | ||
3-Year Change | -84.27% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 60.0M | ||
Total Assets | $262,340.00 | ||
Market Cap | N/A | ||
Enterprise Value | N/A | ||
Period: QTR TTM FY | |||
Revenue | $56.00 | ||
Net Income | -$18,528.00 | ||
Free Cash Flow | $10,128.00 | ||
EBIT | -$11,032.00 | ||
EBITDA | -$11,032.00 | ||
Net Working Capital | -$396,126.00 | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | -2 | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | 59 | ||
Price/Operating Cash Flow | 59 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||